Subsequently, the iNK or CD19 CAR-UiNK cells were intravenously injected into the tumor-bearing animals (1-1.5 × 107 iNK cells/mouse) on Day 0 and Day 7, and PBS was intravenously injected as control. This evidence concerns the gene CD19 and neoplasm.